Gilead to buy biotech firm Ouro Medicines in over $2 billion deal

Gilead to buy biotech firm Ouro Medicines in over $2 billion deal | ReutersSkip to main contentExclusive news, data and analytics for financial market professionalsLearn more aboutRefinitivA Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam/File Photo Purchase Licensing Rights, opens new tabCompaniesGilead Sciences IncFollowMarch 23 (Reuters) - Gilead Sciences (GILD.O), opens new tabsaid on Monday it would buy privately held biotech firm Ouro Medicines i ...